RecruitingNot Applicable

Implementation of IVS3 for Upper Limb Motor Recovery

United States25 participantsStarted 2024-10-02

Plain-language summary

This study measures participant satisfaction and upper extremity function in outpatients with chronic stroke when exposed to the IVS3 device. Investigators hypothesize that treatment with the IVS3 device will be feasible and tolerable for use in the outpatient setting.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age ≥ 18 years old
✓. English speaking
✓. History of ischemic or hemorrhagic stroke ≥ 6 months prior to study enrolment
✓. FMA-UE: 20 \< x \< 50 (moderate impairments)
✓. With or without hemi spatial neglect

Exclusion criteria

✕. Spasticity or increased tone with MAS ≥3 in the upper extremity
✕. Unable to communicate effectively or provide informed consent
✕. Significant visual impairments
✕. Concurrent occupational therapy being received outside of the study
✕. Pregnant or incarcerated individuals

What they're measuring

Mean number of sessions attended

Timeframe: 12 treatment sessions over 4-6 weeks.

Number of serious adverse events

Timeframe: 12 treatment sessions over 4-6 weeks.

Trial details

NCT IDNCT06483230

SponsorWeill Medical College of Cornell University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-03

Contact for this trial

Zhiyan Yang, MS

(212) 746-1509 zhy7009@med.cornell.edu

View on ClinicalTrials.gov More Neglect, Hemispatial trials